Yunxiang Zhou

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Municipal Solid Waste

Pseudomonas Aeruginosa

Severe Traumatic Brain Injury

Top Venues

OncoTargets and therapy

Oxidative medicine and cellular longevity

NPJ breast cancer

Zhejiang University School of Medicine Second Affiliated Hospital

Zhejiang University (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhejiang University School of Medicine Second Affiliated Hospital

China

Doctor :: surgical oncology

Education History

Zhejiang University

China

MSC :: School of Medicine

Zhejiang University

China

BSC :: School of Medicine

Publications

Yunxiang Zhou, Xiaojia Wang, Yiding Chen
Margetuximab: An active alternative for later-line therapy in patients with HER2-positive advanced breast cancer. MedComm 4 (4) (2023)
Yunxiang Zhou, Xianan Guo, Lu Shen, Kexin Liu, Qunan Sun, Yali Wang, Hui Wang, Wenyu Fu, Yihan Yao, Shijie Wu, Huihui Chen, Jili Qiu, Tao Pan, Yongchuan Deng
Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study. OncoTargets and therapy 16 (2023)
Shijie Wu, Lina Qi, Huihui Chen, Kun Zhang, Jiapan He, Xianan Guo, Lu Shen, Yunxiang Zhou, Xi Zhong, Shu Zheng, Jiaojiao Zhou, Yi-Ding Chen
Functional assessment of missense variants of uncertain significance in the cancer susceptibility gene PALB2. NPJ breast cancer 8 (1) (2022)
Xianjun Xuan, Guoyi Zhou, Caihong Chen, Anwen Shao, Yunxiang Zhou, Xiaobo Li, Jiaqi Zhou
Glymphatic System: Emerging Therapeutic Target for Neurological Diseases. Oxidative medicine and cellular longevity 2022 (2022)
Yunxiang Zhou, Yihan Yao, Lesang Sheng, Jianmin Zhang, Arne P Neyrinck, Anwen Shao
Osteopontin as a candidate of therapeutic application for the acute brain injury. Journal of cellular and molecular medicine 24 (16) (2020)